The State of Texas Attorney General Files Lawsuit Against Acetaminophen Makers Over Autism Assertions

The top legal official in Texas Ken Paxton is taking legal action against the producers of Tylenol, asserting the corporations hid potential risks that the medication created to children's neurological development.

This legal action arrives thirty days after President Donald Trump publicized an unproven link between consuming Tylenol - also known as paracetamol - while pregnant and autism in children.

The attorney general is filing suit against J&J, which previously sold the medication, the exclusive pain medication approved for pregnant women, and the current manufacturer, which now manufacturers it.

In a statement, he said they "betrayed America by gaining financially from pain and promoting medication regardless of the dangers."

The company states there is no credible evidence tying acetaminophen to autism.

"These corporations deceived for years, knowingly endangering countless individuals to line their pockets," Paxton, from the Republican party, said.

The manufacturer said in a statement that it was "very worried by the perpetuation of misinformation on the safety of paracetamol and the potential impact that could have on the well-being of US mothers and children."

On its online platform, Kenvue also stated it had "regularly reviewed the pertinent research and there is insufficient valid information that demonstrates a proven link between consuming acetaminophen and autism."

Organizations representing physicians and health professionals concur.

The leading OB-GYN organization has said acetaminophen - the key substance in Tylenol - is a restricted selection for expectant mothers to treat discomfort and fever, which can create serious health risks if not addressed.

"In over twenty years of investigation on the utilization of paracetamol in pregnancy, zero credible investigations has conclusively proven that the consumption of paracetamol in any period of gestation causes neurodevelopmental disorders in young ones," the group commented.

The lawsuit cites recent announcements from the previous government in claiming the drug is potentially dangerous.

In recent weeks, Trump generated worry from medical authorities when he advised pregnant women to "struggle intensely" not to use acetaminophen when ill.

The FDA then published an announcement that physicians should consider limiting the consumption of Tylenol, while also mentioning that "a causal relationship" between the medication and autism spectrum disorder in children has remains unverified.

Health Secretary Robert F Kennedy Jr, who supervises the FDA, had vowed in April to initiate "comprehensive study program" that would establish the cause of autism in a matter of months.

But experts advised that identifying a sole reason of autism spectrum disorder - considered by experts to be the outcome of a complicated interplay of genetic and surrounding conditions - would be difficult.

Autism is a form of permanent neurological difference and condition that affects how individuals encounter and engage with the world, and is identified using physician assessments.

In his lawsuit, the attorney general - aligned with the former president who is seeking federal office - claims Kenvue and Johnson & Johnson "deliberately disregarded and attempted to silence the science" around acetaminophen and autism.

This legal action aims to force the companies "eliminate any promotional materials" that asserts acetaminophen is secure for pregnant women.

The court case echoes the grievances of a group of mothers and fathers of minors with autism spectrum disorder and attention deficit hyperactivity disorder who sued the producers of acetaminophen in 2022.

A federal judge dismissed the legal action, saying research from the plaintiffs' authorities was lacking definitive proof.